There are 360 resources available
28P - Epithelial Mesenchymal transition confers resistance to dual PDL1-VEGF inhibition in relapsed mesothelioma
Presenter: Essa Baitei
Session: Poster Display
29P - Circulating proteins associated with immunotherapy efficacy in patients with pancreatic ductal adenocarcinoma.
Presenter: Troels Christensen
Session: Poster Display
146P - Stereotactic body radiotherapy plus anlotinib ± toripalimab in untreated oligometastatic brain metastases NSCLC patients
Presenter: Guang Han
Session: Poster Display
30P - Frequency of peripheral CD8+ T cells expressing chemo-attractant receptors increases in NPC patients with EBV clearance upon radiotherapy
Presenter: Shweta Mahajan
Session: Poster Display
147P - Characterizing CRS in phase 1 study of DLL3-targeted T-cell engager tarlatamab in small cell lung cancer
Presenter: Stephane Champiat
Session: Poster Display
31P - The IOpener study: tyrosine kinase activity profiling to predict response to immune checkpoint inhibitors in patients with advanced stage non-small cell lung cancer
Presenter: Karlijn Joode
Session: Poster Display
32P - Discovering markers that identify pro-metastatic immune cell subsets.
Presenter: Ansooya Bokil
Session: Poster Display
149P - A phase Ib/II trial of surufatinib plus toripalimab and etoposide(E) combined with cisplatin (P) in patients(pts) with untreated advanced small cell lung cancer (SCLC)
Presenter: Wen Feng Fang
Session: Poster Display